Annual ROA
-50.27%
-13.45%-36.53%
31 December 2023
Summary:
SAB Biotherapeutics annual return on assets is currently -50.27%, with the most recent change of -13.45% (-36.53%) on 31 December 2023. During the last 3 years, it has fallen by -85.85% (-241.29%). SABS annual ROA is now -241.29% below its all-time high of 35.58%, reached on 31 December 2020.SABS ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROA
-67.26%
-1.58%-2.41%
30 September 2024
Summary:
SAB Biotherapeutics quarterly return on assets is currently -67.26%, with the most recent change of -1.58% (-2.41%) on 30 September 2024. Over the past year, it has increased by +1.91% (+2.76%). SABS quarterly ROA is now -2801.20% below its all-time high of 2.49%, reached on 31 March 2021.SABS Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SABS ROA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -36.5% | +2.8% |
| 3 y3 years | -241.3% | -812.6% |
| 5 y5 years | - | - |
SABS ROA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -241.3% | at low | -812.6% | +24.1% |
| 5 y | 5 years | -241.3% | at low | -2801.2% | +24.1% |
| alltime | all time | -241.3% | at low | -2801.2% | +24.1% |
SAB Biotherapeutics ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -67.26%(+2.4%) |
| June 2024 | - | -65.68%(-9.8%) |
| Mar 2024 | - | -72.78%(-17.9%) |
| Dec 2023 | -50.27%(+36.5%) | -88.65%(+28.2%) |
| Sept 2023 | - | -69.17%(+7.6%) |
| June 2023 | - | -64.31%(+29.5%) |
| Mar 2023 | - | -49.65%(+52.3%) |
| Dec 2022 | -36.82% | -32.59%(-5.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | -34.45%(+44.1%) |
| June 2022 | - | -23.90%(+8.7%) |
| Mar 2022 | - | -21.98%(+7.8%) |
| Dec 2021 | -21.13%(-159.4%) | -20.39%(+176.7%) |
| Sept 2021 | - | -7.37%(+166.1%) |
| June 2021 | - | -2.77%(-211.2%) |
| Mar 2021 | - | 2.49% |
| Dec 2020 | 35.58%(-171.3%) | - |
| Dec 2019 | -49.91% | - |
FAQ
- What is SAB Biotherapeutics annual return on assets?
- What is the all time high annual ROA for SAB Biotherapeutics?
- What is SAB Biotherapeutics annual ROA year-on-year change?
- What is SAB Biotherapeutics quarterly return on assets?
- What is the all time high quarterly ROA for SAB Biotherapeutics?
- What is SAB Biotherapeutics quarterly ROA year-on-year change?
What is SAB Biotherapeutics annual return on assets?
The current annual ROA of SABS is -50.27%
What is the all time high annual ROA for SAB Biotherapeutics?
SAB Biotherapeutics all-time high annual return on assets is 35.58%
What is SAB Biotherapeutics annual ROA year-on-year change?
Over the past year, SABS annual return on assets has changed by -13.45% (-36.53%)
What is SAB Biotherapeutics quarterly return on assets?
The current quarterly ROA of SABS is -67.26%
What is the all time high quarterly ROA for SAB Biotherapeutics?
SAB Biotherapeutics all-time high quarterly return on assets is 2.49%
What is SAB Biotherapeutics quarterly ROA year-on-year change?
Over the past year, SABS quarterly return on assets has changed by +1.91% (+2.76%)